This is a preview of subscription content, log in to check access.
Buy single article
Instant unlimited access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Allen LF, et al. Cost-Effectiveness of Avatrombopag for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease. 61st Annual Meeting and Exposition of the American Society of Hematology : abstr. 3454, 7 Dec 2019. Available from: URL: https://ash.confex.com/ash/2019/webprogram/Paper131822.html
About this article
Cite this article
Avatrombopag cost effective for thrombocytopenia. PharmacoEcon Outcomes News 844, 6 (2020) doi:10.1007/s40274-020-6469-2